Outcome of patients receiving thrombolytic therapy while on Rivaroxaban for nonvalvular atrial fibrillation (from Rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
The American journal of cardiology
Year: 2017, Jahrgang: 120, Heft: 102, Pages: 1837-1840 |
| ISSN: | 1879-1913 |
| Online-Zugang: | Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0002914917313012?via%3Dihub
|
| Verfasserangaben: | Sean T. Chen, Anne S. Hellkamp, Richard C. Becker, Scott D.Berkowitz, Günter Breithardt, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Christopher C. Nessel, Jonathan P. Piccini, Daniel E. Singer and Manesh R. Patel |
| Beschreibung: | Gesehen am: 23.10.2017 |
|---|---|
| Beschreibung: | Online Resource |
| ISSN: | 1879-1913 |